OpenURL Connection Search

Select item for more details and to access through your institution.

Clinical Utility of Epigenetic Changes in Pancreatic Adenocarcinoma.
Published in:
Epigenomes, 2021, v. 5, n. 4, p. 1, doi. 10.3390/epigenomes5040020
By:
- Thompson, Joyce K.;
- Bednar, Filip
Publication type:
Article
Extracellular Signal-Regulated Kinase 5 and Cyclic AMP Response Element Binding Protein Are Novel Pathways Inhibited by Vandetanib (ZD6474) and Doxorubicin in Mesotheliomas.
Published in:
American Journal of Respiratory Cell & Molecular Biology, 2014, v. 51, n. 5, p. 595, doi. 10.1165/rcmb.2013-0373TR
By:
- Sayan, Mutlay;
- Shukla, Arti;
- MacPherson, Maximilian B.;
- Macura, Sherrill L.;
- Hillegass, Jedd M.;
- Perkins, Timothy N.;
- Thompson, Joyce K.;
- Beuschel, Stacie L.;
- Miller, Jill M.;
- Mossman, Brooke T.
Publication type:
Article
Asbestos modulates thioredoxin-thioredoxin interacting protein interaction to regulate inflammasome activation.
Published in:
Particle & Fibre Toxicology, 2014, v. 11, n. 1, p. 2, doi. 10.1186/1743-8977-11-24
By:
- Thompson, Joyce K.;
- Westbom, Catherine M.;
- MacPherson, Maximilian B.;
- Mossman, Brooke T.;
- Heintz, Nicholas H.;
- Spiess, Page;
- Shukla, Arti
Publication type:
Article
Asbestos and erionite prime and activate the NLRP3 inflammasome that stimulates autocrine cytokine release in human mesothelial cells.
Published in:
Particle & Fibre Toxicology, 2013, v. 10, n. 1, p. 1, doi. 10.1186/1743-8977-10-39
By:
- Hillegass, Jedd M;
- Miller, Jill M;
- MacPherson, Maximilian B;
- Westbom, Catherine M;
- Sayan, Mutlay;
- Thompson, Joyce K;
- Macura, Sherrill L;
- Perkins, Timothy N;
- Beuschel, Stacie L;
- Alexeeva, Vlada;
- Pass, Harvey I;
- Steele, Chad;
- Mossman, Brooke T;
- Shukla, Arti
Publication type:
Article
Malignant Mesothelioma: Development to Therapy.
Published in:
Journal of Cellular Biochemistry, 2014, v. 115, n. 1, p. 1, doi. 10.1002/jcb.24642
By:
- Thompson, Joyce K.;
- Westbom, Catherine M.;
- Shukla, Arti
Publication type:
Article
Inflammasome Modulation by Chemotherapeutics in Malignant Mesothelioma.
Published in:
PLoS ONE, 2015, v. 10, n. 12, p. 1, doi. 10.1371/journal.pone.0145404
By:
- Westbom, Catherine;
- Thompson, Joyce K.;
- Leggett, Alan;
- MacPherson, Maximilian;
- Beuschel, Stacie;
- Pass, Harvey;
- Vacek, Pamela;
- Shukla, Arti
Publication type:
Article
Therapeutic targeting of differentiation-state dependent metabolic vulnerabilities in diffuse midline glioma.
Published in:
Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-52973-4
By:
- Mbah, Nneka E.;
- Myers, Amy L.;
- Sajjakulnukit, Peter;
- Chung, Chan;
- Thompson, Joyce K.;
- Hong, Hanna S.;
- Giza, Heather;
- Dang, Derek;
- Nwosu, Zeribe C.;
- Shan, Mengrou;
- Sweha, Stefan R.;
- Maydan, Daniella D.;
- Chen, Brandon;
- Zhang, Li;
- Magnuson, Brian;
- Zhu, Zirui;
- Radyk, Megan;
- Lavoie, Brooke;
- Yadav, Viveka Nand;
- Koo, Imhoi
Publication type:
Article

Found: 7

Clinical Utility of Epigenetic Changes in Pancreatic Adenocarcinoma.

Extracellular Signal-Regulated Kinase 5 and Cyclic AMP Response Element Binding Protein Are Novel Pathways Inhibited by Vandetanib (ZD6474) and Doxorubicin in Mesotheliomas.

Asbestos modulates thioredoxin-thioredoxin interacting protein interaction to regulate inflammasome activation.

Asbestos and erionite prime and activate the NLRP3 inflammasome that stimulates autocrine cytokine release in human mesothelial cells.

Malignant Mesothelioma: Development to Therapy.

Inflammasome Modulation by Chemotherapeutics in Malignant Mesothelioma.

Therapeutic targeting of differentiation-state dependent metabolic vulnerabilities in diffuse midline glioma.